메뉴 건너뛰기




Volumn 35, Issue 4, 2014, Pages 540-548

Discovery and characterization of novel smallmolecule agonists of G protein-coupled receptor 119

Author keywords

AR231453; cAMP; GPCR; GPR119; High throughput screening; Insulin; Obesity; PSN632408; Type 2 diabetes mellitus; cell

Indexed keywords

1 [[4 (5 CYCLOPROPYL 1,2,4 OXADIAZOL 3 YL)PHENYL]SULFONYL] N [(TETRAHYDROFURAN 2 YL)METHYL]PIPERIDINE 4 CARBOXAMIDE; 4 ETHYL 2 [3 (4 PHENYLPIPERAZINE 1 CARBONYL)PIPERIDIN 1 YL]PYRIDO[2,3 B]PYRAZIN 3(4H) ONE; 4 ETHYL 2 [3 [4 (4 METHOXYPHENYL)PIPERAZINE 1 CARBONYL]PIPERIDIN 1 YL]PYRIDO[2,3 B]PYRAZIN 3(4H) ONE; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 119; G PROTEIN COUPLED RECEPTOR 119 AGONIST; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG; ZSY 04; ZSY 06; ZSY 13; ANTIDIABETIC AGENT; GLUCOSE; GPR119 PROTEIN, HUMAN; GPR119 PROTEIN, MOUSE; INSULIN; MOLECULAR LIBRARY;

EID: 84898744571     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2014.8     Document Type: Article
Times cited : (17)

References (33)
  • 1
    • 84858225542 scopus 로고    scopus 로고
    • Novel pharmacological approaches to the treatment of type 2 diabetes
    • Verspohl EJ. Novel pharmacological approaches to the treatment of type 2 diabetes. Pharmacol Rev 2012; 64: 188-237
    • (2012) Pharmacol Rev , vol.64 , pp. 188-237
    • Verspohl, E.J.1
  • 2
    • 79959936188 scopus 로고    scopus 로고
    • National regional and global trends in fasting plasma glucose and diabetes prevalence since 1980 systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants
    • Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378: 31-40
    • (2011) Lancet , vol.378 , pp. 31-40
    • Paciorek, C.J.1    Lin, J.K.2    Farzadfar, F.3    Khang, Y.H.4    Stevens, G.A.5    Rao, M.6
  • 3
    • 84882261930 scopus 로고    scopus 로고
    • Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: The metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach
    • Nadeau DA. Physiologic and weight-focused treatment strategies for managing type 2 diabetes mellitus: The metformin, glucagon-like peptide-1 receptor agonist, and insulin (MGI) approach. Postgrad Med 2013; 125: 112-26
    • (2013) Postgrad Med , vol.125 , pp. 112-126
    • Nadeau, D.A.1
  • 6
    • 33744915759 scopus 로고    scopus 로고
    • G protein-coupled receptors for free fatty acids
    • Milligan G, Stoddart LA, Brown AJ. G protein-coupled receptors for free fatty acids. Cell Signal 2006; 18: 1360-5
    • (2006) Cell Signal , vol.18 , pp. 1360-1365
    • Milligan, G.1    Stoddart, L.A.2    Brown, A.J.3
  • 8
    • 57349135245 scopus 로고    scopus 로고
    • Identification of G protein-coupled receptor 120-selective agonists derived from PPARgamma agonists
    • Suzuki T, Igari S, Hirasawa A, Hata M, Ishiguro M, Fujieda H, et al. Identification of G protein-coupled receptor 120-selective agonists derived from PPARgamma agonists. J Med Chem 2008; 51: 7640-4
    • (2008) J Med Chem , vol.51 , pp. 7640-7644
    • Suzuki, T.1    Igari, S.2    Hirasawa, A.3    Hata, M.4    Ishiguro, M.5    Fujieda, H.6
  • 9
    • 78049341843 scopus 로고    scopus 로고
    • Cannabinoid receptors are coupled to stimulation of insulin secretion from mouse MIN6 beta-cells
    • Li C, Jones PM, Persaud SJ. Cannabinoid receptors are coupled to stimulation of insulin secretion from mouse MIN6 beta-cells. Cell Physiol Biochem 2010; 26: 187-96
    • (2010) Cell Physiol Biochem , vol.26 , pp. 187-196
    • Li, C.1    Jones, P.M.2    Persaud, S.J.3
  • 10
    • 84880180346 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 receptor-mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic beta-cells
    • Kuna RS, Girada SB, Asalla S, Vallentyne J, Maddika S, Patterson JT, et al. Glucagon-like peptide-1 receptor-mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic beta-cells. Am J Physiol Endocrinol Metab 2013; 305: E161-70
    • (2013) Am J Physiol Endocrinol Metab , vol.305
    • Kuna, R.S.1    Girada, S.B.2    Asalla, S.3    Vallentyne, J.4    Maddika, S.5    Patterson, J.T.6
  • 11
    • 33750520737 scopus 로고    scopus 로고
    • Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: Predominant localization in pancreatic polypeptide-secreting PP-cells
    • Sakamoto Y, Inoue H, Kawakami S, Miyawaki K, Miyamoto T, Mizuta K, et al. Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: Predominant localization in pancreatic polypeptide-secreting PP-cells. Biochem Biophys Res Commun 2006; 351: 474-80
    • (2006) Biochem Biophys Res Commun , vol.351 , pp. 474-480
    • Sakamoto, Y.1    Inoue, H.2    Kawakami, S.3    Miyawaki, K.4    Miyamoto, T.5    Mizuta, K.6
  • 12
    • 34248527678 scopus 로고    scopus 로고
    • A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release
    • Chu ZL, Jones RM, He H, Carroll C, Gutierrez V, Lucman A, et al. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology 2007; 148: 2601-9
    • (2007) Endocrinology , vol.148 , pp. 2601-2609
    • Chu, Z.L.1    Jones, R.M.2    He, H.3    Carroll, C.4    Gutierrez, V.5    Lucman, A.6
  • 13
    • 42449126696 scopus 로고    scopus 로고
    • A role for intestinal endocrine cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release
    • Chu ZL, Carroll C, Alfonso J, Gutierrez V, He H, Lucman A, et al. A role for intestinal endocrine cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release. Endocrinology 2008; 149: 2038-47
    • (2008) Endocrinology , vol.149 , pp. 2038-2047
    • Chu, Z.L.1    Carroll, C.2    Alfonso, J.3    Gutierrez, V.4    He, H.5    Lucman, A.6
  • 14
    • 10644275303 scopus 로고    scopus 로고
    • Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor
    • Soga T, Ohishi T, Matsui T, Saito T, Matsumoto M, Takasaki J, et al. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 2005; 326: 744-51
    • (2005) Biochem Biophys Res Commun , vol.326 , pp. 744-751
    • Soga, T.1    Ohishi, T.2    Matsui, T.3    Saito, T.4    Matsumoto, M.5    Takasaki, J.6
  • 15
    • 56749170734 scopus 로고    scopus 로고
    • Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells
    • Ning Y, O'Neill K, Lan H, Pang L, Shan LX, Hawes BE, et al. Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. Br J Pharmacol 2008; 155: 1056-65
    • (2008) Br J Pharmacol , vol.155 , pp. 1056-1065
    • Ning, Y.1    O'Neill, K.2    Lan, H.3    Pang, L.4    Shan, L.X.5    Hawes, B.E.6
  • 16
    • 67649913243 scopus 로고    scopus 로고
    • GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis
    • Lan H, Vassileva G, Corona A, Liu L, Baker H, Golovko A, et al. GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. J Endocrinol 2009; 201: 219-30
    • (2009) J Endocrinol , vol.201 , pp. 219-230
    • Lan, H.1    Vassileva, G.2    Corona, A.3    Liu, L.4    Baker, H.5    Golovko, A.6
  • 17
    • 65549142522 scopus 로고    scopus 로고
    • GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell
    • Lauffer LM, Iakoubov R, Brubaker PL. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 2009; 58: 1058-66
    • (2009) Diabetes , vol.58 , pp. 1058-1066
    • Lauffer, L.M.1    Iakoubov, R.2    Brubaker, P.L.3
  • 20
    • 41549138447 scopus 로고    scopus 로고
    • Development of a universal high-Throughput calcium assay for G-protein-coupled receptors with promiscuous G-protein Galpha15/16
    • Zhu T, Fang LY, Xie X. Development of a universal high-Throughput calcium assay for G-protein-coupled receptors with promiscuous G-protein Galpha15/16. Acta Pharmacol Sin 2008; 29: 507-16
    • (2008) Acta Pharmacol Sin , vol.29 , pp. 507-516
    • Zhu, T.1    Fang, L.Y.2    Xie, X.3
  • 21
    • 36148996843 scopus 로고    scopus 로고
    • G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes
    • Winzell MS, Ahren B. G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol Ther 2007; 116: 437-48
    • (2007) Pharmacol Ther , vol.116 , pp. 437-448
    • Winzell, M.S.1    Ahren, B.2
  • 22
    • 67349176115 scopus 로고    scopus 로고
    • Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
    • Ahren B. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat Rev Drug Discov 2009; 8: 369-85
    • (2009) Nat Rev Drug Discov , vol.8 , pp. 369-385
    • Ahren, B.1
  • 23
    • 70349988797 scopus 로고    scopus 로고
    • G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell
    • Morgan NG, Dhayal S. G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell. Biochem Pharmacol 2009; 78: 1419-27
    • (2009) Biochem Pharmacol , vol.78 , pp. 1419-1427
    • Morgan, N.G.1    Dhayal, S.2
  • 24
    • 67649979936 scopus 로고    scopus 로고
    • GPR119 agonists: A promising new approach for the treatment of type 2 diabetes and related metabolic disorders
    • Shah U. GPR119 agonists: A promising new approach for the treatment of type 2 diabetes and related metabolic disorders. Curr Opin Drug Discov Devel 2009; 12: 519-32
    • (2009) Curr Opin Drug Discov Devel , vol.12 , pp. 519-532
    • Shah, U.1
  • 25
    • 51849099001 scopus 로고    scopus 로고
    • Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119
    • Semple G, Fioravanti B, Pereira G, Calderon I, Uy J, Choi K, et al. Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119. J Med Chem 2008; 51: 5172-5
    • (2008) J Med Chem , vol.51 , pp. 5172-5175
    • Semple, G.1    Fioravanti, B.2    Pereira, G.3    Calderon, I.4    Uy, J.5    Choi, K.6
  • 26
    • 33644627958 scopus 로고    scopus 로고
    • Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents
    • Overton HA, Babbs AJ, Doel SM, Fyfe MC, Gardner LS, Griffin G, et al. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 2006; 3: 167-75
    • (2006) Cell Metab , vol.3 , pp. 167-175
    • Overton, H.A.1    Babbs, A.J.2    Doel, S.M.3    Fyfe, M.C.4    Gardner, L.S.5    Griffin, G.6
  • 27
    • 77956936188 scopus 로고    scopus 로고
    • Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion
    • Yoshida S, Ohishi T, Matsui T, Shibasaki M. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion. Biochem Biophys Res Commun 2010; 400: 437-41
    • (2010) Biochem Biophys Res Commun , vol.400 , pp. 437-441
    • Yoshida, S.1    Ohishi, T.2    Matsui, T.3    Shibasaki, M.4
  • 28
    • 78149470681 scopus 로고    scopus 로고
    • Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice
    • Yoshida S, Ohishi T, Matsui T, Tanaka H, Oshima H, Yonetoku Y, et al. Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. Biochem Biophys Res Commun 2010; 402: 280-5
    • (2010) Biochem Biophys Res Commun , vol.402 , pp. 280-285
    • Yoshida, S.1    Ohishi, T.2    Matsui, T.3    Tanaka, H.4    Oshima, H.5    Yonetoku, Y.6
  • 29
    • 77957274682 scopus 로고    scopus 로고
    • AS1907417, a novel GPR119 agonist, as an insulinotropic and beta-cell preservative agent for the treatment of type 2 diabetes
    • Yoshida S, Tanaka H, Oshima H, Yamazaki T, Yonetoku Y, Ohishi T, et al. AS1907417, a novel GPR119 agonist, as an insulinotropic and beta-cell preservative agent for the treatment of type 2 diabetes. Biochem Biophys Res Commun 2010; 400: 745-51
    • (2010) Biochem Biophys Res Commun , vol.400 , pp. 745-751
    • Yoshida, S.1    Tanaka, H.2    Oshima, H.3    Yamazaki, T.4    Yonetoku, Y.5    Ohishi, T.6
  • 30
    • 78649687741 scopus 로고    scopus 로고
    • The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic beta-cell function
    • Yoshida S, Ohishi T, Matsui T, Tanaka H, Oshima H, Yonetoku Y, et al. The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic beta-cell function. Diabetes Obes Metab 2011; 13: 34-41
    • (2011) Diabetes Obes Metab , vol.13 , pp. 34-41
    • Yoshida, S.1    Ohishi, T.2    Matsui, T.3    Tanaka, H.4    Oshima, H.5    Yonetoku, Y.6
  • 31
    • 80054988309 scopus 로고    scopus 로고
    • Pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-38431055, a novel GPR119 receptor agonist and potential antidiabetes agent, in healthy male subjects
    • Katz LB, Gambale JJ, Rothenberg PL, Vanapalli SR, Vaccaro N, Xi L, et al. Pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-38431055, a novel GPR119 receptor agonist and potential antidiabetes agent, in healthy male subjects. Clin Pharmacol Ther 2011; 90: 685-92
    • (2011) Clin Pharmacol Ther , vol.90 , pp. 685-692
    • Katz, L.B.1    Gambale, J.J.2    Rothenberg, P.L.3    Vanapalli, S.R.4    Vaccaro, N.5    Xi, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.